Dogwood Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Gregory Duncan, with a market cap of $66.1M.
Common questions about Dogwood Therapeutics
Dogwood Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026.
Dogwood Therapeutics has approximately 4 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.